Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01940311
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
KJ2 | 4-{4-[4-(3-AMINOPROPOXY)PHENYL]- 1H-PYRAZOL-5-YL}-6-CHLOROBENZENE- 1,3-DIOL | A,B | 2BRE | 0.72 | |
76A | 3-(4'-HYDROXYBIPHENYL-4-YL)-N-(4- HYDROXYCYCLOHEXYL)-1,4-DIHYDROINDENO[1,2- C]PYRAZOLE-6-CARBOXAMIDE | A | 2E9N | 0.71 | |
A4L | 9-[(5-(ACETYLAMINO)-6-{[(1S,4R)- 8-AMINO-4-[((2R)-6-AMINO-2-{2-[(1S)- 5-AMINO-1-FORMYLPENTYL]HYDRAZINO}HEXANOYL)AMINO]- 1-(4-AMINOBUTYL)-2,3-DIOXOOCTYL]AMINO}- 6-OXOHEXYL)AMINO]-6-CHLORO-2-METHOXYACRIDINIUM | A,B | 1XCS | 0.72 | |
2E1 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE- 3-CARBOXAMIDE | A | 2CCT | 0.79 | |
FRI | 2-GUANIDINO-4-METHYL-PENTANOIC ACID [2- (4-{5-[4-(4-ACETYLAMINO-BENZYLOXY)- 2,3-DICHLORO-PHENYL]-2-METHYL-2H- PYRAZOL-3-YL}-PIPERIDIN-1-YL)-2- OXO-ETHYL]-AMIDE | A,B,C,D | 1QVN | 0.71 | |
P4A | 4-[4-(4-methoxyphenyl)-5-methyl- 1H-pyrazol-3-yl]benzene-1,3-diol | A,B | 2ZDX | 0.72 | |
AIZ | 3-{6-[(2-CHLOROPHENYL)AMINO]-1H- INDAZOL-3-YL}-5-{[4-(DIMETHYLAMINO)BUTANOYL]AMINO}BENZOIC ACID | A | 2B1P | 0.74 | |
IMN | INDOMETHACIN | A | 2BXM | 0.73 | |
IMN | INDOMETHACIN | A | 3FO7 | 0.73 | |
IMN | INDOMETHACIN | A,B,C,D | 1Z9H | 0.73 | |
IMN | INDOMETHACIN | A | 2BXQ | 0.73 | |
IMN | INDOMETHACIN | A,B,C,D | 4COX | 0.73 | |
IMN | INDOMETHACIN | A | 2ALT | 0.73 | |
IMN | INDOMETHACIN | A | 2OTH | 0.73 | |
IMN | INDOMETHACIN | A,B | 2DM6 | 0.73 | |
IMN | INDOMETHACIN | A | 1S2A | 0.73 | |
IMN | INDOMETHACIN | A | 2ZB8 | 0.73 | |
IMN | INDOMETHACIN | A | 3HWZ | 0.73 | |
IMN | INDOMETHACIN | A | 2BXK | 0.73 | |
BSM | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)-1H- PYRAZOLE-3-CARBOXAMIDE | A | 2BSM | 0.86 | |
2D7 | N-(4-ACETYLPHENYL)-5-(5-CHLORO- 2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE- 4-CARBOXAMIDE | A | 2BYH | 0.78 | |
FRH | 5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO- 4-METHYL-PENTANOYLAMINO)-ACETYL]- PIPERIDIN-4-YL}-1-METHYL-1H-PYRAZOL- 3-YL)-PHENOXYMETHYL]-FURAN-2-CARBOXYLIC ACID | A,B,C,D | 1PY2 | 0.7 | |
IMS | 2-[1-(4-CHLOROBENZOYL)-5-METHOXY- 2-METHYL-1H-INDOL-3-YL]-N-[(1S)- 1-(HYDROXYMETHYL)PROPYL]ACETAMIDE | P | 2OYU | 0.73 | |
IM8 | 2-[1-(4-CHLOROBENZOYL)-5-METHOXY- 2-METHYL-1H-INDOL-3-YL]-N-[(1R)- 1-(HYDROXYMETHYL)PROPYL]ACETAMIDE | P | 2OYE | 0.73 | |
2GG | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE- 3-CARBOXAMIDE | A | 2UWD | 0.74 | |
4BC | 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL- 2,4-DIHYDROXYPHENYL)-2H-PYRAZOLE- 3-CARBOXYLIC ACID | A | 1YC3 | 0.72 | |
4BC | 4-(1,3-BENZODIOXOL-5-YL)-5-(5-ETHYL- 2,4-DIHYDROXYPHENYL)-2H-PYRAZOLE- 3-CARBOXYLIC ACID | A | 1YC1 | 0.72 | |
GG2 | 1-(4-METHOXYPHENYL)-7-OXO-6-[4- (2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE- 3-CARBOXAMIDE | A | 2P16 | 0.7 |